Onyx Healthcare Inc. (TPEX:6569)
97.30
-3.20 (-3.18%)
Jul 29, 2026, 1:30 PM CST
Onyx Healthcare Market Cap
Onyx Healthcare has a market cap or net worth of 3.8 billion as of July 29, 2026. Its market cap has decreased by -12.22% in one year.
Market Cap
3.80B
Enterprise Value
3.87B
Revenue
1.38B
Ranking
n/a
PE Ratio
26.26
Stock Price
97.30
ChartMarket Cap Chart
Since January 15, 2016, Onyx Healthcare's market cap has increased from 1.94B to 3.80B, an increase of 96.31%. That is a compound annual growth rate of 6.61%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 3.82B | -10.78% |
| Dec 31, 2025 | 4.28B | -27.59% |
| Dec 31, 2024 | 5.91B | 2.52% |
| Dec 29, 2023 | 5.76B | 77.16% |
| Dec 30, 2022 | 3.25B | 2.87% |
| Dec 30, 2021 | 3.16B | -11.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 492.63B |
| Caliway Biopharmaceuticals | 158.75B |
| Pell Bio-Med Technology | 64.08B |
| Heron Neutron Medical | 62.44B |
| Bionime | 4.43B |
| Sinew Pharma | 4.41B |
| LIWANLI Innovation | 4.27B |
| Orient EuroPharma | 4.08B |